EpicentRx and Texas Children’s Cancer Center announce the initiation of a Phase 1 clinical trial with RRx-001 for pediatric CNS tumors 02/24/2022 Health Briefs min. read Copied to clipboard Topics cancer solid tumors brain tumors Read Full media story at www.epicentrx.com Related Stories Health Briefs Mar 20, 2025 Alex’s Lemonade Stand Foundation Celebrates 25 Years of Fighting Childhood Cancer with Breakthr... Read more Health Briefs Nov 01, 2024 Outpatient CAR T: Safe, Effective, Accessible MedScape Health Briefs Aug 15, 2024 TULIPs in brain tumors could be exploited therapeutically Read more Health Briefs Jul 23, 2024 Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’ Read more Health Briefs Jul 23, 2024 Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’ Read more Health Briefs Jul 18, 2024 Unexpected role of OTX2 drives aggressive medulloblastoma Read more See more results 80506 EpicentRx and Texas Children’s Cancer Center announce the initiation of a Phase 1 clinical trial with RRx-001 for pediatric CNS tumors Health Briefs Article